[English] 日本語
Yorodumi- PDB-7uzd: Structure of the SARS-CoV-2 RBD in complex with the mouse antibod... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 7uzd | ||||||
|---|---|---|---|---|---|---|---|
| Title | Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, HSW-2 | ||||||
Components |
| ||||||
Keywords | IMMUNE SYSTEM/VIRAL PROTEIN / immune system / neutralizing antibody / IMMUNE SYSTEM-VIRAL PROTEIN complex | ||||||
| Function / homology | Function and homology informationsymbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion ...symbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / membrane fusion / entry receptor-mediated virion attachment to host cell / Attachment and Entry / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / receptor ligand activity / endocytosis involved in viral entry into host cell / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont entry into host cell / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / identical protein binding / membrane / plasma membrane Similarity search - Function | ||||||
| Biological species | ![]() ![]() | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3 Å | ||||||
Authors | Fan, C. / Bjorkman, P.J. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Immunity / Year: 2022Title: Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes. Authors: Chengcheng Fan / Alexander A Cohen / Miso Park / Alfur Fu-Hsin Hung / Jennifer R Keeffe / Priyanthi N P Gnanapragasam / Yu E Lee / Han Gao / Leesa M Kakutani / Ziyan Wu / Harry Kleanthous / ...Authors: Chengcheng Fan / Alexander A Cohen / Miso Park / Alfur Fu-Hsin Hung / Jennifer R Keeffe / Priyanthi N P Gnanapragasam / Yu E Lee / Han Gao / Leesa M Kakutani / Ziyan Wu / Harry Kleanthous / Kathryn E Malecek / John C Williams / Pamela J Bjorkman / ![]() Abstract: Increased immune evasion by SARS-CoV-2 variants of concern highlights the need for new therapeutic neutralizing antibodies. Immunization with nanoparticles co-displaying spike receptor-binding ...Increased immune evasion by SARS-CoV-2 variants of concern highlights the need for new therapeutic neutralizing antibodies. Immunization with nanoparticles co-displaying spike receptor-binding domains (RBDs) from eight sarbecoviruses (mosaic-8 RBD-nanoparticles) efficiently elicits cross-reactive polyclonal antibodies against conserved sarbecovirus RBD epitopes. Here, we identified monoclonal antibodies (mAbs) capable of cross-reactive binding and neutralization of animal sarbecoviruses and SARS-CoV-2 variants by screening single mouse B cells secreting IgGs that bind two or more sarbecovirus RBDs. Single-particle cryo-EM structures of antibody-spike complexes, including a Fab-Omicron complex, mapped neutralizing mAbs to conserved class 1/4 RBD epitopes. Structural analyses revealed neutralization mechanisms, potentials for intra-spike trimer cross-linking by IgGs, and induced changes in trimer upon Fab binding. In addition, we identified a mAb-resembling Bebtelovimab, an EUA-approved human class 3 anti-RBD mAb. These results support using mosaic RBD-nanoparticle vaccination to generate and identify therapeutic pan-sarbecovirus and pan-variant mAbs. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 7uzd.cif.gz | 139.8 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb7uzd.ent.gz | 104.8 KB | Display | PDB format |
| PDBx/mmJSON format | 7uzd.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 7uzd_validation.pdf.gz | 718.2 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 7uzd_full_validation.pdf.gz | 723.6 KB | Display | |
| Data in XML | 7uzd_validation.xml.gz | 22.9 KB | Display | |
| Data in CIF | 7uzd_validation.cif.gz | 31.4 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/uz/7uzd ftp://data.pdbj.org/pub/pdb/validation_reports/uz/7uzd | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 7uz4C ![]() 7uz5C ![]() 7uz6C ![]() 7uz7C ![]() 7uz8C ![]() 7uz9C ![]() 7uzaC ![]() 7uzbC ![]() 7uzcC ![]() 7sc1S S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 25994.311 Da / Num. of mol.: 1 / Fragment: RBD Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Gene: S, 2 / Production host: Homo sapiens (human) / References: UniProt: P0DTC2 |
|---|---|
| #2: Antibody | Mass: 24869.686 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human) |
| #3: Antibody | Mass: 23442.080 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human) |
| #4: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source |
| Has ligand of interest | Y |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 3.74 Å3/Da / Density % sol: 67.11 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, sitting drop Details: 0.2 M sodium chloride, 0.1 M sodium/potassium phosphate pH 6.5, 25 % PEG 1000 |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SSRL / Beamline: BL12-2 / Wavelength: 0.97946 Å |
| Detector | Type: DECTRIS PILATUS 6M / Detector: PIXEL / Date: Dec 9, 2021 |
| Radiation | Monochromator: Si(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.97946 Å / Relative weight: 1 |
| Reflection | Resolution: 3→39.08 Å / Num. obs: 23278 / % possible obs: 99.8 % / Redundancy: 26.1 % / Biso Wilson estimate: 81.09 Å2 / CC1/2: 0.998 / Rmerge(I) obs: 0.233 / Rpim(I) all: 0.047 / Rrim(I) all: 0.238 / Χ2: 0.93 / Net I/σ(I): 12.3 |
| Reflection shell | Resolution: 3→3.18 Å / Redundancy: 26.2 % / Rmerge(I) obs: 2.533 / Mean I/σ(I) obs: 3.2 / Num. unique obs: 3661 / CC1/2: 0.354 / Rpim(I) all: 0.506 / Rrim(I) all: 2.586 / Χ2: 0.88 / % possible all: 99.1 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 7SC1 Resolution: 3→39.08 Å / SU ML: 0.48 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 30.71 / Stereochemistry target values: ML
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 161.82 Å2 / Biso mean: 72.9851 Å2 / Biso min: 38.65 Å2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 3→39.08 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 8
|
Movie
Controller
About Yorodumi





X-RAY DIFFRACTION
United States, 1items
Citation

















PDBj






Homo sapiens (human)